GovChime
Notice ID: bc17a6fefc6640d4b8b15062cf70eb72Sources SoughtArchived

Q301--NGS Malignancy Testing

Archived on September 12, 2026. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
12:00 PM EDT
Posted
July 9, 2026
Notice type
Sources Sought
NAICS
621511: Medical Laboratories
Agency
Department of Veterans Affairs

Notice details

Office
250-NETWORK CONTRACT OFFICE 10 (36C250)
Place of performance
Richard L. Roudebush VAMC 1481 W. 10th St., Indianapolis, Indiana, 46202
PSC
Q301: REFERENCE LABORATORY TESTING
Last updated
Oct 28, 2026
First published
Last updated on SAM.gov

Identifiers

Solicitation number
36C25026Q0709
Notice ID
bc17a6fefc6640d4b8b15062cf70eb72

Description

SOURCES SOUGHT NOTICE This Sources Sought Notice is to determine the presence of any businesses capable of satisfying a requirement at the Richard L. Roudebush VAMC for Hematologic Malignancy Next Generation Sequence (NGS) complex specialized testing and Immunohistochemistry (IHC) testing and analysis of patient specimens. NOTE TO RESPONDERS: This Sources Sought Notice is for planning purposes only and shall not be considered as an invitation for bid, request for quotation, request for proposal, or as an obligation on the part of the Government to acquire any products or services. Your response to this Sources Sought Notice will be treated as information only. No entitlement to payment of direct or indirect costs or charges by the Government will arise as a result of contractor submission of responses to this announcement or the Government use of such information. This request does not constitute a solicitation for proposals or the authority to enter negotiations to award a contract. No funds have been authorized, appropriated, or received for this effort. BACKGROUND The Hematology department at Richard L. Roudebush VA Medical Center s Pathology & Laboratory Medicine Service (PALMS) requires a one-year, firm fixed price contract for Hematologic Malignancy Next Generation Sequence (NGS) complex specialized testing and Immunohistochemistry (IHC) testing and analysis of patient specimens. NGS testing is an advanced test methodology at the gene level for detecting various forms of diseases through patient blood specimens. Testing shall provide detailed gene test results of at least 600 targeted genes and produce detailed treatment plans. This contract is needed for Hematology providers to obtain repeat NGS testing that may not be covered under the VA National Precision Oncology Program (NPOP) national contract, for patients with changes in their diagnosis. North American Industry Classification System (NAICS) code: 621511 VENDOR CAPABILITY Interested and qualified vendors are encouraged to respond with: Your company s point of contact s name, street address, e-mail address, telephone number, UEI & sam.gov registration, NAICS code, and Socio-economic status (Small Business, Woman Owned Small Business, Service-Disabled Veteran Owned Small Business, etc.), and GSA/FSS Contract Number (if applicable). A capability statement that adequately describes the contractor s ability to meet the requirement. Contractor shall provide any applicable past performance on contracts of this nature. Please provide no more than three (3) examples. Interested parties are responsible for adequately marking proprietary information contained in their response. The Government does not intend to pay for the information submitted in response to this Sources Sought Notice. All information received in response to this notice that is marked as proprietary will be handled accordingly. GOVERNMENT POINT OF CONTACT No phone calls will be accepted. Responses will only be accepted via email, no later than Tuesday July 14, 2026, at 12pm EST. Primary Point of Contact: Jessica D. Bryant Contract Specialist E-mail: Jessica.Bryant5@va.gov Secondary Point of Contact: Tiera T. Sims Contract Specialist E-mail: Tiera.Sims@va.gov

Full description on SAM.gov

Award Overview

Contacts

Contracting Officer

Primary Contact

Jessica D. Bryant
Contract Specialist

Documents

Files (2)

  • NGS Statement of Work 2026.pdf

    718 KBAdded in Sources Sought version 3Posted
    Download
  • 36C25026Q0709.docx

    18 KBAdded in Sources Sought version 3Posted
    Download

Lifecycle

  1. 3
    Version 3Sources SoughtArchivedCurrent

    Q301--NGS Malignancy Testing

    Notice bc17a6fefc6640d4b8b15062cf70eb72 on SAM.gov

Similar Opportunities

Additional Details

Solicitation Number

36C25026Q0709

Archive Date

Sep 12, 2026

Office Address

DAYTON, OH, 45428